- call +1-201-465-4211
- email sales@mrinsights.biz
A vaccine is a biological preparation consisting of an agent that closely resembles a disease-causing microorganism and is made from weakened or killed forms of the microbe, its toxins or one of its surface proteins.
Scope of the Report:
This report focuses on the H1N1 Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The global H1N1 vaccination market is anticipated to boost in the focus period due to the rising cases of swine flu. Additionally, the rising geriatric population increases the risk of respiratory tract diseases, and immune deficient diseases, thus increasing the risk factor for acquiring H1N1 influenza. Moreover, increased research in the field of vaccine technologies and significant government support are driving this market. However, lack of awareness and absence of experienced medical professionals are restraining the growth of H1N1 vaccines market. Furthermore, high capital requirement and stringent regulations are also hindering the growth of the global H1N1 vaccination market.
The Americas led the global H1N1 vaccines market and is expected to reach close to USD 2 billion by 2020. Factors such as the higher incidences of H1N1 infections in the US and the affordability of treatment due to well-structured reimbursement health plans to propel this market’s growth in the region. Furthermore, the increasing use of combination vaccines and the introduction of novel vaccines is anticipated to drive the growth of this market in the Americas.
The worldwide market for H1N1 Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Abbott
Baxter International
Sanofi
GSK
Pfizer
Mitsubishi Tanabe Pharma
Hualan Biological Engineering
Cipla
Merck
Sinovac Biotech
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Intramuscular Vaccines
Intranasal Vaccines
Intradermal Vaccines
Market Segment by Applications, can be divided into
Influenza
Meningococcal
Cervical Cancer
Pneumococcal
Hepatitis
Measles
Mumps
Rubella
Others
There are 15 Chapters to deeply display the global H1N1 Vaccines market.
Chapter 1, to describe H1N1 Vaccines Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of H1N1 Vaccines, with sales, revenue, and price of H1N1 Vaccines, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of H1N1 Vaccines, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, H1N1 Vaccines market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe H1N1 Vaccines sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 H1N1 Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Intramuscular Vaccines
1.2.2 Intranasal Vaccines
1.2.3 Intradermal Vaccines
1.3 Market Analysis by Applications
1.3.1 Influenza
1.3.2 Meningococcal
1.3.3 Cervical Cancer
1.3.4 Pneumococcal
1.3.5 Hepatitis
1.3.6 Measles
1.3.7 Mumps
1.3.8 Rubella
1.3.9 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Abbott
2.1.1 Business Overview
2.1.2 H1N1 Vaccines Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott H1N1 Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Baxter International
2.2.1 Business Overview
2.2.2 H1N1 Vaccines Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Baxter International H1N1 Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Sanofi
2.3.1 Business Overview
2.3.2 H1N1 Vaccines Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Sanofi H1N1 Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 GSK
2.4.1 Business Overview
2.4.2 H1N1 Vaccines Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 GSK H1N1 Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Pfizer
2.5.1 Business Overview
2.5.2 H1N1 Vaccines Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Pfizer H1N1 Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Mitsubishi Tanabe Pharma
2.6.1 Business Overview
2.6.2 H1N1 Vaccines Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Mitsubishi Tanabe Pharma H1N1 Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Hualan Biological Engineering
2.7.1 Business Overview
2.7.2 H1N1 Vaccines Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Hualan Biological Engineering H1N1 Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Cipla
2.8.1 Business Overview
2.8.2 H1N1 Vaccines Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Cipla H1N1 Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Merck
2.9.1 Business Overview
2.9.2 H1N1 Vaccines Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Merck H1N1 Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Sinovac Biotech
2.10.1 Business Overview
2.10.2 H1N1 Vaccines Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Sinovac Biotech H1N1 Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global H1N1 Vaccines Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global H1N1 Vaccines Sales and Market Share by Manufacturer (2016-2017)
3.2 Global H1N1 Vaccines Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 H1N1 Vaccines Manufacturer Market Share in 2017
3.3.2 Top 6 H1N1 Vaccines Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global H1N1 Vaccines Market Analysis by Regions
4.1 Global H1N1 Vaccines Sales, Revenue and Market Share by Regions
4.1.1 Global H1N1 Vaccines Sales and Market Share by Regions (2013-2018)
4.1.2 Global H1N1 Vaccines Revenue and Market Share by Regions (2013-2018)
4.2 North America H1N1 Vaccines Sales and Growth Rate (2013-2018)
4.3 Europe H1N1 Vaccines Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific H1N1 Vaccines Sales and Growth Rate (2013-2018)
4.5 South America H1N1 Vaccines Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa H1N1 Vaccines Sales and Growth Rate (2013-2018)
5 North America H1N1 Vaccines by Countries
5.1 North America H1N1 Vaccines Sales, Revenue and Market Share by Countries
5.1.1 North America H1N1 Vaccines Sales and Market Share by Countries (2013-2018)
5.1.2 North America H1N1 Vaccines Revenue and Market Share by Countries (2013-2018)
5.2 United States H1N1 Vaccines Sales and Growth Rate (2013-2018)
5.3 Canada H1N1 Vaccines Sales and Growth Rate (2013-2018)
5.4 Mexico H1N1 Vaccines Sales and Growth Rate (2013-2018)
6 Europe H1N1 Vaccines by Countries
6.1 Europe H1N1 Vaccines Sales, Revenue and Market Share by Countries
6.1.1 Europe H1N1 Vaccines Sales and Market Share by Countries (2013-2018)
6.1.2 Europe H1N1 Vaccines Revenue and Market Share by Countries (2013-2018)
6.2 Germany H1N1 Vaccines Sales and Growth Rate (2013-2018)
6.3 UK H1N1 Vaccines Sales and Growth Rate (2013-2018)
6.4 France H1N1 Vaccines Sales and Growth Rate (2013-2018)
6.5 Russia H1N1 Vaccines Sales and Growth Rate (2013-2018)
6.6 Italy H1N1 Vaccines Sales and Growth Rate (2013-2018)
7 Asia-Pacific H1N1 Vaccines by Countries
7.1 Asia-Pacific H1N1 Vaccines Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific H1N1 Vaccines Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific H1N1 Vaccines Revenue and Market Share by Countries (2013-2018)
7.2 China H1N1 Vaccines Sales and Growth Rate (2013-2018)
7.3 Japan H1N1 Vaccines Sales and Growth Rate (2013-2018)
7.4 Korea H1N1 Vaccines Sales and Growth Rate (2013-2018)
7.5 India H1N1 Vaccines Sales and Growth Rate (2013-2018)
7.6 Southeast Asia H1N1 Vaccines Sales and Growth Rate (2013-2018)
8 South America H1N1 Vaccines by Countries
8.1 South America H1N1 Vaccines Sales, Revenue and Market Share by Countries
8.1.1 South America H1N1 Vaccines Sales and Market Share by Countries (2013-2018)
8.1.2 South America H1N1 Vaccines Revenue and Market Share by Countries (2013-2018)
8.2 Brazil H1N1 Vaccines Sales and Growth Rate (2013-2018)
8.3 Argentina H1N1 Vaccines Sales and Growth Rate (2013-2018)
8.4 Colombia H1N1 Vaccines Sales and Growth Rate (2013-2018)
9 Middle East and Africa H1N1 Vaccines by Countries
9.1 Middle East and Africa H1N1 Vaccines Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa H1N1 Vaccines Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa H1N1 Vaccines Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia H1N1 Vaccines Sales and Growth Rate (2013-2018)
9.3 UAE H1N1 Vaccines Sales and Growth Rate (2013-2018)
9.4 Egypt H1N1 Vaccines Sales and Growth Rate (2013-2018)
9.5 Nigeria H1N1 Vaccines Sales and Growth Rate (2013-2018)
9.6 South Africa H1N1 Vaccines Sales and Growth Rate (2013-2018)
10 Global H1N1 Vaccines Market Segment by Type
10.1 Global H1N1 Vaccines Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global H1N1 Vaccines Sales and Market Share by Type (2013-2018)
10.1.2 Global H1N1 Vaccines Revenue and Market Share by Type (2013-2018)
10.2 Intramuscular Vaccines Sales Growth and Price
10.2.1 Global Intramuscular Vaccines Sales Growth (2013-2018)
10.2.2 Global Intramuscular Vaccines Price (2013-2018)
10.3 Intranasal Vaccines Sales Growth and Price
10.3.1 Global Intranasal Vaccines Sales Growth (2013-2018)
10.3.2 Global Intranasal Vaccines Price (2013-2018)
10.4 Intradermal Vaccines Sales Growth and Price
10.4.1 Global Intradermal Vaccines Sales Growth (2013-2018)
10.4.2 Global Intradermal Vaccines Price (2013-2018)
11 Global H1N1 Vaccines Market Segment by Application
11.1 Global H1N1 Vaccines Sales Market Share by Application (2013-2018)
11.2 Influenza Sales Growth (2013-2018)
11.3 Meningococcal Sales Growth (2013-2018)
11.4 Cervical Cancer Sales Growth (2013-2018)
11.5 Pneumococcal Sales Growth (2013-2018)
11.6 Hepatitis Sales Growth (2013-2018)
11.7 Measles Sales Growth (2013-2018)
11.8 Mumps Sales Growth (2013-2018)
11.9 Rubella Sales Growth (2013-2018)
11.10 Others Sales Growth (2013-2018)
12 H1N1 Vaccines Market Forecast (2018-2023)
12.1 Global H1N1 Vaccines Sales, Revenue and Growth Rate (2018-2023)
12.2 H1N1 Vaccines Market Forecast by Regions (2018-2023)
12.2.1 North America H1N1 Vaccines Market Forecast (2018-2023)
12.2.2 Europe H1N1 Vaccines Market Forecast (2018-2023)
12.2.3 Asia-Pacific H1N1 Vaccines Market Forecast (2018-2023)
12.2.4 South America H1N1 Vaccines Market Forecast (2018-2023)
12.2.5 Middle East and Africa H1N1 Vaccines Market Forecast (2018-2023)
12.3 H1N1 Vaccines Market Forecast by Type (2018-2023)
12.3.1 Global H1N1 Vaccines Sales Forecast by Type (2018-2023)
12.3.2 Global H1N1 Vaccines Market Share Forecast by Type (2018-2023)
12.4 H1N1 Vaccines Market Forecast by Application (2018-2023)
12.4.1 Global H1N1 Vaccines Sales Forecast by Application (2018-2023)
12.4.2 Global H1N1 Vaccines Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure H1N1 Vaccines Picture
Table Product Specifications of H1N1 Vaccines
Figure Global Sales Market Share of H1N1 Vaccines by Types in 2017
Table H1N1 Vaccin
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
